Abstract |
Tyrosine kinase inhibitors (TKIs) are now the mainstay of treatment in many types of cancer. However, their benefit is frequently short-lived, mandating the search for safe potentiation strategies. Cycles of fasting enhance the activity of chemo- radiotherapy in preclinical cancer models and dietary approaches based on fasting are currently explored in clinical trials. Whether combining fasting with TKIs is going to be potentially beneficial remains unknown. Here we report that starvation conditions increase the ability of commonly administered TKIs, including erlotinib, gefitinib, lapatinib, crizotinib and regorafenib, to block cancer cell growth, to inhibit the mitogen-activated protein kinase (MAPK) signaling pathway and to strengthen E2F-dependent transcription inhibition. In cancer xenografts models, both TKIs and cycles of fasting slowed tumor growth, but, when combined, these interventions were significantly more effective than either type of treatment alone. In conclusion, cycles of fasting or of specifically designed fasting-mimicking diets should be evaluated in clinical studies as a means to potentiate the activity of TKIs in clinical use.
|
Authors | Irene Caffa, Vito D'Agostino, Patrizia Damonte, Debora Soncini, Michele Cea, Fiammetta Monacelli, Patrizio Odetti, Alberto Ballestrero, Alessandro Provenzani, Valter D Longo, Alessio Nencioni |
Journal | Oncotarget
(Oncotarget)
Vol. 6
Issue 14
Pg. 11820-32
(May 20 2015)
ISSN: 1949-2553 [Electronic] United States |
PMID | 25909220
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Protein Kinase Inhibitors
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Fasting
(physiology)
- Female
- Heterografts
- Humans
- Immunoblotting
- MAP Kinase Signaling System
(drug effects)
- Mice
- Mice, Inbred BALB C
- Neoplasms
(metabolism)
- Oligonucleotide Array Sequence Analysis
- Protein Kinase Inhibitors
(pharmacology)
- Real-Time Polymerase Chain Reaction
|